We previously reported high levels of CD109 expression in various tumor cell lines and tumor tissues including SCCs of the lung, esophagus, uterus and oral cavity; malignant melanoma of the skin; and urothelial carcinoma of the urinary bladder [12–20]. The gene discussed is CD109; the disease is neoplasm.